Arvinas, Inc.
ARVN- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001655759
No open-market purchases or sales by Arvinas, Inc. insiders were filed in the last 90 days; 201 institutions reported holding it in 13F filings for Q2 2026, worth $468.7M in total; no superinvestor holds it.
13F holders, Q1 2022
Institutional positions in Arvinas, Inc. as of Mar 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 179
- −18 vs. Q4 2021
- Shares held
- 46.9M
- +1.95M (+4.3%) vs. Q4 2021
- Total value
- $3.16B
- −$535.4M (−14.5%) vs. Q4 2021
- New holders
- 22
- 61 more added
- Sold out
- 40
- 72 more reduced
2 institutions that held it in Q4 2021 haven't filed for Q1 2022 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q4 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ARVN on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 201 | $468.7M |
| Q1 2026 | 207 | $572.6M |
| Q4 2025 | 206 | $662.9M |
| Q3 2025 | 211 | $570.7M |
| Q2 2025 | 215 | $513.8M |
| Q1 2025 | 216 | $456.7M |
| Q4 2024 | 199 | $1.47B |
| Q3 2024 | 206 | $1.78B |
| Q2 2024 | 207 | $1.89B |
| Q1 2024 | 223 | $2.84B |
| Q4 2023 | 213 | $2.67B |
| Q3 2023 | 155 | $959.0M |
| Q2 2023 | 156 | $1.16B |
| Q1 2023 | 171 | $1.34B |
| Q4 2022 | 162 | $1.71B |
| Q3 2022 | 174 | $2.22B |
| Q2 2022 | 172 | $2.08B |
| Q1 2022 | 179 | $3.16B |
| Q4 2021 | 199 | $3.69B |
| Q3 2021 | 205 | $3.64B |
| Q2 2021 | 181 | $3.52B |
| Q1 2021 | 181 | $2.88B |
Institutions, Q1 2022
Shares, value and share of portfolio for each institution holding Arvinas, Inc.; share changes are against Q4 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| SEI Investments Co | 0 | $0 | 0.00% | −5,412−100.0% | Sold out |
| Brinker Capital Investments, LLC | 0 | $0 | 0.00% | −4,774−100.0% | Sold out |
| Advisory Research Inc | 0 | $0 | 0.00% | −4,390−100.0% | Sold out |
| Utah Retirement Systems | 0 | $0 | 0.00% | −3,678−100.0% | Sold out |
| Manteio Capital LLC | 0 | $0 | 0.00% | −3,282−100.0% | Sold out |
| Man Group plc | 0 | $0 | 0.00% | −2,796−100.0% | Sold out |
| Schonfeld Strategic Advisors LLC | 0 | $0 | 0.00% | −2,800−100.0% | Sold out |
| Bay Colony Advisory Group, Inc d/b/a Bay Colony Advisors | 0 | $0 | 0.00% | −2,625−100.0% | Sold out |
| Magnetar Financial LLC | 0 | $0 | 0.00% | −2,506−100.0% | Sold out |
| Dark Forest Capital Management LP | 0 | $0 | 0.00% | −1,554−100.0% | Sold out |
| Group One Trading, L.P. | 0 | $0 | 0.00% | −1,074−100.0% | Sold out |
| Cutler Group LP | 0 | $0 | 0.00% | −1,000−100.0% | Sold out |
| Aquatic Capital Management LLC | 0 | $0 | 0.00% | −600−100.0% | Sold out |
| First Quadrant L P | 0 | $0 | 0.00% | −572−100.0% | Sold out |
| Migdal Insurance & Financial Holdings Ltd. | 0 | $0 | 0.00% | −155−100.0% | Sold out |
| HM Payson & Co | 0 | $0 | 0.00% | −96−100.0% | Sold out |
| Simplex Trading, LLC | 0 | $0 | 0.00% | −77−100.0% | Sold out |
| Massmutual Trust Co FSB | 0 | $0 | 0.00% | −8−100.0% | Sold out |
| Private Capital Group, LLC | 0 | $0 | 0.00% | −17−100.0% | Sold out |
| Harbour Investments, Inc. | – | – | – | – | Not filed |
| Bell Investment Advisors, Inc | – | – | – | – | Not filed |